1,3,7-Trimethylxanthine

GPTKB entity

Statements (51)
Predicate Object
gptkbp:instanceOf gptkb:chemical_compound
alkaloid
xanthine derivative
gptkbp:affects gptkb:adenosine_receptors
phosphodiesterase enzymes
gptkbp:aroma odorless
gptkbp:boilingPoint 178 °C (sublimes)
gptkbp:CASNumber 58-08-2
gptkbp:chemicalFormula C8H10N4O2
gptkbp:color white
gptkbp:commonName caffeine
gptkbp:crystalForm powder
gptkbp:discoveredBy gptkb:Friedlieb_Ferdinand_Runge
gptkbp:discoveredIn 1819
gptkbp:drugClass stimulant
diuretic
cardiac stimulant
gptkbp:eliminationHalfLife 3–7 hours (adults)
up to 100 hours (newborns)
gptkbp:excretion urine
gptkbp:foundIn gptkb:guarana
gptkb:café
gptkb:yerba_mate
cocoa
cola
gptkbp:hasInChIKey RYYVLZVUVIJVGH-UHFFFAOYSA-N
gptkbp:hasSMILES Cn1cnc2c1c(=O)n(C)c(=O)n2C
https://www.w3.org/2000/01/rdf-schema#label 1,3,7-Trimethylxanthine
gptkbp:IUPACName 1,3,7-Trimethylpurine-2,6-dione
gptkbp:legalStatus generally recognized as safe (GRAS)
gptkbp:meltingPoint 235–238 °C
gptkbp:metabolism gptkb:theophylline
liver
theobromine
gptkbp:molecularWeight 194.19 g/mol
gptkbp:PubChem_CID 2519
27732
DB00201
gptkbp:routeOfAdministration oral
intravenous
gptkbp:sideEffect nervousness
insomnia
tachycardia
gastrointestinal disturbance
gptkbp:solubility 2.17 g/100 mL (25 °C)
gptkbp:UNII 3G6A5W338E
gptkbp:usedAs stimulant
ingredient in beverages
medication for apnea of prematurity
gptkbp:bfsParent gptkb:DB03128
gptkbp:bfsLayer 8